10.46243/jst.2020.v5.i04.pp215-222 registered
LC-MS/MS-Based Selective Degradant Separation and Mass Spectral Characterization of Viloxazine
Resolves to https://www.jst.org.in/index.php/pub/article/view/664
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2020.v5.i04.pp215-222
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 870a8b86e5d34cc0…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
LC-MS/MS-Based Selective Degradant Separation and Mass Spectral Characterization of Viloxazine (PrincipalTitle · en)
Published 2020-08-27
Part of Journal of Science & Technology · ISSN 2456-5660 · volume 05 · issue 04 · pages 215–222
Agents
- Shivaprasad (author)
- Adithyamathur (author)
- Dr.Ratnasre (author)
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2020.v5.i04.pp215-222
Abstract · en
This study presents a unique method for the selective extraction of degradants from API using HPLC and online connection of a SCIEX QTRAP 5500 mass spectrometer with a triple quadrupole mass analyzer and PDA detector. Chromatography was employed using mobile phase ACN: 0.1% TEA (40:60) %v/v to separate all degradants on the Agilent Eclipse XDB (150 mm x 4.6 mm, 3.5 μ) column. It was discovered that the maximum absorption occurs at 220 nm, allowing for simultaneous detection unaffected by the placebo matrix. It was decided to approve the recommended RP-HPLC technique in accordance with the general ICH guidelines. The parameters that were considered adequate were specificity, linearity, LoD, LoQ, accuracy, precision, and robustness of validation. The suggested approach demonstrates excellent linearity and robust correlation over the range of 12.5–75 μg/mL. The precision tests' percent RSD was less than 2%, whilst the accuracy trials yielded consistent recoveries (95–105%). It may be possible to determine the inherent stability of the drug molecules in the present formulation by doing forced degradation tests and evaluating the degradation products generated under different stress conditions. By using MS/MS analyses, the generated degradants were further described and effectively isolated. Validation studies showed that the recently developed method is stable and sensitive to all degradants. Validation studies show that within the required operating range, the newly created approach was also linear, accurate, precise, robust, and selective.
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2020.v5.i04.pp215-222 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | LC-MS/MS-Based Selective Degradant Separation and Mass Spectral Characterization of Viloxazine (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | author: Shivaprasad author: Adithyamathur author: Dr.Ratnasre publisher: Longman Publishers published: 2020-08-27 part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 05 · no. 04 · pp. 215–222 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2026-09-10 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 6 references; 2 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 1 | ref1 Viloxazine hydrochloride. Am J Health Syst Pharm [Internet]. 2021 [cited 2022 Jun 10];78(17):1544–7. Available from: https:// go.drugbank.com/salts/DBSALT001262 | 10.1093/ajhp/zxab231 | not held here |
| 3 | ref3 Yu C, Garcia-Olivares J, Candler S, Schwabe S, Maletic V. New insights into the mechanism of action of viloxazine: serotonin and norepinephrine modulating properties. Journal of E… | 10.2147/jep.s256586 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 76 fields set · sha256 b7bff369f824… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.
Changes made at Crossref through DOI Doctor
Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.
| When | What changed | Crossref | Fingerprint |
|---|---|---|---|
| 11 Sep 2026, 05:17 | Address updated from https://www.jst.org.in/index.php/pub/article/view/664/592 to https://www.jst.org.in/index.php/pub/article/view/664 | ● accepted by Crossref | 0516a6e8156a… |
| 12 Sep 2026, 01:39 | Licence added https://creativecommons.org/licenses/by/4.0 | ● accepted by Crossref | 4dd636666428… |
| 13 Sep 2026, 01:39 | Read back: the DOI resolves to the new address | ● confirmed | f8c2d5f95d00… |
| 21 Sep 2026, 00:54 | Metadata completed publication date | ● waiting for Crossref's answer | 83de18dbeae9… |
| 21 Sep 2026, 01:43 | Read back: Crossref's record shows it | ● confirmed | 0ddaa24b1934… |
5 entries · the last fingerprint 0ddaa24b193433fdedb81b4c748a080cec8c4a0550e3812616bf1bc432b2e2bc · the history as JSON, each entry with the fingerprint before it, to check them yourself.



